Highlights and Quick Summary
- Annual 10Y Revenue Growth (CAGR) for 2021 was 17.51% (a -3.9% decrease from previous year)
- Annual 10Y Revenue Growth (CAGR) for 2021 was 18.22% (a -222.28% decrease from previous year)
- Annual 10Y Revenue Growth (CAGR) for 2016 was -14.9% (a -3.31% decrease from previous year)
Visit stockrow.com/BFAGY
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical 10Y Revenue Growth (CAGR) of Biofrontera AG Sponsored ADR
Most recent 10Y Revenue Growth (CAGR)of BFAGY including historical data for past 10 years.Interactive Chart of 10Y Revenue Growth (CAGR) of Biofrontera AG Sponsored ADR
Biofrontera AG Sponsored ADR 10Y Revenue Growth (CAGR) for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2021 | – | – | – | – | 17.51% |
| 2016 | – | – | – | – | -14.9% |
Business Profile of Biofrontera AG Sponsored ADR
Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic